Company

Neocor Therapeutics

Biotechnology Research La Ciotat, Bouches-du-rhône, Fr 6 employees

Employees: 6

neocor.fr LinkedIn

Neocor Therapeutics Overview

Headquarters: La Ciotat, Bouches-du-rhône, Fr
Website: neocor.fr
Industry: Biotechnology Research
Employees: 6
Founded: 2023
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

gene therapy biotechnology rare disease cardiology

About Neocor Therapeutics

We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials.